American pharmaceutical and consumer packaged goods manufacturer has set up shop in Nairobi Kenya and Accra Ghana representing a novel approach to how Johnson & Johnson seeks to develop partnerships, products and service delivery models that address neglected and emerging health issues.
Teams from the company’s consumer, medical device, pharmaceutical, global public health and Global Community Impact (GCI) groups will be located in a central office in each country, helping to bring an integrated approach to improving health outcomes in the region.
“The expansion of our companies’ operations in Africa allows Johnson & Johnson to continue to build innovative, collaborative opportunities that meet a variety of market needs, including developing new pharmaceutical products, service delivery approaches and advocacy for health issues impacting vulnerable communities,” said Alma Scott, Head of Africa Operations and Partnerships, Global Public Health. “Through regional engagement with health delivery partners, we seek to support locally-executable programs that drive health impact.”
The Johnson & Johnson Family of Companies have a strong legacy in Africa. More than 80 years ago, South Africa was selected as the company’s third overseas location and has steadily expanded its footprint in Africa to 27 countries.
Today, Johnson & Johnson operates three manufacturing plants and employs more than 1,500 employees in Africa who serve the region’s diverse health needs through our consumer, commercial, global public health and corporate citizenship programs.
jnj.com
